⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6311076 | 0.67 | — | — | |
| SCHEMBL489240 | 0.65 | — | — | |
| SCHEMBL10512993 | 0.60 | — | — | |
| SCHEMBL12304947 | 0.56 | — | — | |
| SCHEMBL15800051 | 0.56 | — | — | |
| SCHEMBL9718515 | 0.56 | — | — | |
| SCHEMBL3065887 | 0.56 | — | — | |
| SCHEMBL13939824 | 0.56 | — | — | |
| SCHEMBL175401 | 0.56 | — | — | |
| SCHEMBL3074875 | 0.52 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5292875-A | Method of synthesizing sulfurized oligonucleotide analogs | LYNX THERAPEUTICS, INC. (US) | 1994-03-08 | — | — | US | claimed |
| EP-0524942-B1 | METHOD OF SYNTHESIZING SULFURIZED OLIGONUCLEOTIDE ANALOGS | LYNX THERAPEUTICS INC (US) | 1998-04-15 | — | — | EP | disclosed |
| US-5292875-A | Method of synthesizing sulfurized oligonucleotide analogs | LYNX THERAPEUTICS, INC. (US) | 1994-03-08 | — | — | US | disclosed |
| US-5292875-A | Method of synthesizing sulfurized oligonucleotide analogs | LYNX THERAPEUTICS, INC. (US) | 1994-03-08 | — | — | US | disclosed |
| EP-0524942-A4 | METHOD OF SYNTHESIZING SULFURIZED OLIGONUCLEOTIDE ANALOGS | — | 1993-07-21 | — | — | EP | disclosed |
| EP-0524942-A1 | METHOD OF SYNTHESIZING SULFURIZED OLIGONUCLEOTIDE ANALOGS | LYNX THERAPEUTICS, INC. (US) | 1993-02-03 | — | — | EP | disclosed |
| EP-0524942-A1 | METHOD OF SYNTHESIZING SULFURIZED OLIGONUCLEOTIDE ANALOGS | LYNX THERAPEUTICS, INC. (US) | 1993-02-03 | — | — | EP | disclosed |
| US-5151510-A | METHOD OF SYNETHESIZING SULFURIZED OLIGONUCLEOTIDE ANALOGS | APPLIED BIOSYSTEMS, INC. (US) | 1992-09-29 | — | — | US | disclosed |
| US-5151510-A | METHOD OF SYNETHESIZING SULFURIZED OLIGONUCLEOTIDE ANALOGS | APPLIED BIOSYSTEMS, INC. (US) | 1992-09-29 | — | — | US | disclosed |
| WO-1991016331-A1 | METHOD OF SYNTHESIZING SULFURIZED OLIGONUCLEOTIDE ANALOGS | APPLIED BIOSYSTEMS, INC. (US) | 1991-10-31 | — | — | WO | disclosed |
| WO-1991016331-A1 | METHOD OF SYNTHESIZING SULFURIZED OLIGONUCLEOTIDE ANALOGS | APPLIED BIOSYSTEMS, INC. (US) | 1991-10-31 | — | — | WO | disclosed |